HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Zacks #1 Rank
See how a purely mathematical analysis of earnings estimate revisions returns over 28% per year on average. Click Here to Learn More.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Top 10 Stocks
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


BDX: Becton Dickinson & Co - Stock Quote Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Quote |  Detailed Quotes |  Real Time |  Options Chain |  Greeks Montage

BECTON DICKINSON & CO (NYSE)
BDX 75.26 0.58 (0.78%) Vol.  1,185,830 16:01 ET

Day Low - High 74.33 - 75.66
52wk Low - High 60.40 - 79.97
Avg Volume 1,306,282
Industry MED/DENTAL-SUPP
Market Cap 17.69 B
Div - Yield 1.48 - 1.98
PE (forward) 14.57
PEG Ratio 1.27
Current Year Est. 5.13
EPS Last Year 5.03
Detailed Quote


Premium Research: Stock Analysis

Zacks Rank

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Zacks Rank Definition Annualized Return
# 1Buy12%
# 2Strong Sell50.23%
# 3Hold14%
# 4Sell3.97%
# 5Hold1.85%
S&P50012.22%
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank


downgraded 02/03/2010
Short-Term Rating 1-3 Months
PREMIUM
Zacks Recommendation

Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.

The Zacks Recommendations are split into 3 groups: Outperform, Neutral and Underperform. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock. More on these reports below.

Difference Between Zacks Rank and Zacks Recommendation
Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations


Long-Term Rating 6+ Months
PREMIUM
Zacks Industry Rank

Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.

When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

About Zacks Industry Rank
Zacks Industry Rank - All current industry ranks.
Zacks Premium - The only way to get access to the Zacks Industry Rank

PREMIUM
Target Price

The Zacks Price Target provides you our expectation for a stocks share price in the next 6 months. These price targets are created by the Zacks Equity Research group to coincide with their recommendations that are also based on a 6 month time horizon.

Zacks Equity Research Home
Zacks Premium - The only way to get access to the Zacks Price Targets

PREMIUM
Equity Research Report

The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

Zacks Equity Research Home Zacks Premium - The only way to get access to Zacks Recommendations


Updated as of 02/02/2010
PREMIUM
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium

Premium Research: Industry Analysis

Top Peers Ticker Zacks Rank
BECTON DICKINSON & CO BDX PREMIUM
MWI VET SUPPLY MWIV PREMIUM
BIO REFERNC LAB BRLI PREMIUM
INVACARE CORP IVC PREMIUM
See all MED/DENTAL-SUPP Peers

BROKERAGE RECOMMENDATIONS
Current ABR 2.27
ABR (Last Week) 2.27
# of Recs in ABR 15
Average Target Price 81.50
Industry Rank by ABR 128 out of 217
Rank in Industry 25 out of 33
More Brokerage Recommendations

Zacks Community PeopleAndPicks.com
Community Rating

PeopleAndPicks.com Community Stock Ratings

Rating Recommendation % of Stocks
5 stars Strong Buy 10%
4 stars Buy 20%
3 stars Hold 40%
2 stars Sell 20%
1 stars Strong Sell 10%
0 stars Not Rated  

We believe that a community of investors working together can create a superior stock rating system. Some call this "collective intelligence". Or simply...together we can beat the market!

A stock's Community Rating is calculated based on the aggregate input of the PeopleAndPicks Community. The proportion of buy to sell ratings, recency of analysis, and the average score of the users who rate it favorably all factor into a score of one to five stars.


How do you rate BDX?
Buy
Sell
Find out what the Zacks Community
thinks of BDX at PeopleAndPicks.com

NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

 Interactive Java Charting
 Comparative Chart



 
ZACKS COMMENTARY FOR BDX
Zacks Blog: Becton Recalls Catheters
Feb 09, 2010
Zacks Blog: Baxter Downgraded
Feb 05, 2010
Zacks Blog: Zacks Analyst Blog Highlights: Whirlpool Corporation, Toyota Motor Corp., Archer Daniels Midland Company, Becton, Dickinson and Company and Baxter International...
Feb 03, 2010
Zacks Blog: Becton Beats, Bumps Estimates
Feb 02, 2010
Zacks Blog: Zacks Industry Outlook Highlights: Medtronic, Inc., Surgical, Inc., Boston Scientific Corporation, St. Jude Medical Inc. and Becton, Dickinson and Company
Feb 02, 2010
Zacks Equity Research: Report for BDX
Feb 02, 2010
Zacks Blog: Medical Devices Stock Review - Feb. 2010
Feb 01, 2010
Zacks Analyst Interviews: Medical Devices Stock Review - Feb. 2010
Feb 01, 2010
More Zacks Commentary
NEWS
Chairman Richard Kinder Buys $1.3M Worth of Kinder Morgan - TheStreet.com
Feb 09, 2010
BD Announces Worldwide Voluntary Recall of BD Q-Syte(TM) Luer Access Devices and BD Nexiva(TM) Closed IV Catheter Systems
Feb 08, 2010
Becton Dickinson Recalls I.V. Devices - FOXBusiness.com
Feb 08, 2010
Becton Dickinson (BDX) Showing Support at 75.75 With Neutral Technicals
Feb 05, 2010
SmarTrend's Candlestick Scanner Detects Bearish Inside Day Pattern for Becton Dickinson (BDX)
Feb 04, 2010
BD Launches 'Be a Flu Fighter' Campaign to Promote Influenza Awareness and Prevention in Schools, Hospitals and Laboratories
Feb 03, 2010
Becton, Dickinson Declares 37 Cent Dividend
Feb 03, 2010
Zacks Industry Outlook Highlights: Medtronic, Inc., Surgical, Inc., Boston Scientific Corporation, St. Jude Medical Inc. and Becton, Dickinson and Company
Feb 02, 2010
More News
EARNINGS ESTIMATES
  This Quarter
03/2010
Next Quarter
06/2010
This Year
09/2010
Next Year
09/2011
Average Estimate 1.23 1.29 5.13 5.60
Number of Estimates 14 14 16 16
Low Estimates 1.19 1.26 5.07 5.51
High Estimate 1.28 1.33 5.19 5.74
Year Ago EPS 1.18 1.30 4.95 5.13
EPS Growth 4.36% -0.49% 3.55% 9.23%

More Estimates

COMPANY DESCRIPTION
Becton, Dickinson and Co. is engaged principally in the manufacture and sale of a broad line of supplies, devices and systems used by health care professionals, medical research institutions and the general public. BD's operations consist of three worldwide business segments: Medical Systems, Biosciences, and Preanalytical Solutions.

Full Company Report
FINANCIALS
EPS TTM 5.03
Sales 7160.87
Net Income 1235.9
Price/Earnings 14.85
Price/Book 3.48
Price/Cash Flow 10.58
Price/Sales 2.4


More Financials

 
About Zacks | Advertise | Affiliate | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2010 Zacks Investment Research